Emer­gent sells once-trou­bled man­u­fac­tur­ing site to In­di­an CD­MO

Emer­gent BioSo­lu­tions is sell­ing a man­u­fac­tur­ing site in Bal­ti­more — which has a his­to­ry of con­t­a­m­i­nat­ed Covid-19 vac­cines — for $36.5 mil­lion to In­dia-head­quar­tered CD­MO Syn­gene. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER